Filing Flows › Parabilis Medicines (PBLS) › Next earnings date
Parabilis Medicines (PBLS) earnings on Nov 12, 2026: what to expect
Parabilis Medicines (PBLS) is expected to report earnings on Nov 12, 2026 (estimated), in 4 days, for the quarter ending Sep 30, 2026. Analysts expect EPS of −$0.38 (−$0.45 to −$0.25, 3 estimates) on revenue of $500K. It beat the EPS estimate in 0% of the quarters on record; Filing Flows' model gives it a 58% chance of beating next time.
The last report
Parabilis Medicines reported revenue of $148K for the second quarter 2026, net loss $52.5M. How it makes money → · Every quarter →
Parabilis Medicines' latest quarter
Parabilis Medicines, Q2 2026: revenue $148K, net loss $52.5M. The chart follows the revenue to costs, profit and cash.
Questions
When does PBLS report earnings?
Parabilis Medicines is expected to report on Nov 12, 2026 (estimated).
What are analysts expecting from Parabilis Medicines?
EPS of −$0.38 and revenue of $500K for the quarter.
Does Parabilis Medicines usually beat earnings?
It beat the consensus EPS estimate in 0% of the quarters on record.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.